Sign In
Buy GLMD
$0.621
+0.0220 (+3.67%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
Analysts Offer Insights on Healthcare Companies: Akero Therapeutics (AKRO) and Blueprint Medicines (BPMC)
10:10am, Wednesday, 18'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akero Therapeutics (AKRO) and Blueprint Medicines (BPMC)
Analysts Offer Insights on Healthcare Companies: Akero Therapeutics (NASDAQ: AKRO) and Blueprint Medicines (NASDAQ: BPMC)
10:10am, Wednesday, 18'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akero Therapeutics (
AKRO
–
Research Report
) and Blueprint Medicines (
BPMC
–
Research Report
) wi
B.Riley FBR Maintains Their Buy Rating on Galmed Pharmaceuticals (GLMD)
12:18pm, Monday, 16'th Mar 2020
B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Galmed Pharmaceuticals (GLMD) on March 13 and set a price target of $11.00. The company's
B.Riley FBR Maintains Their Buy Rating on Galmed Pharmaceuticals (GLMD)
12:18pm, Monday, 16'th Mar 2020
B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Galmed Pharmaceuticals (GLMD – Research Report) on March 13 and
Analysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (GLMD) and MyoKardia (MYOK)
10:48am, Monday, 16'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals (GLMD) and MyoKardia (MYOK) with
Analysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (NASDAQ: GLMD) and MyoKardia (NASDAQ: MYOK)
10:47am, Monday, 16'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals (
GLMD
–
Research Report
) and MyoKardia (
MYOK
–
Research Report
) with bul
Analysts Offer Insights on Healthcare Companies: Sientra (SIEN), Nabriva (NBRV) and Galmed Pharmaceuticals (GLMD)
11:30am, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sientra (SIEN), Nabriva (NBRV) and Galmed Pharmaceuticals
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sientra (
SIEN
–
Research Report
), Nabriva (
NBRV
–
Research Report
) and Galmed Pharmaceuticals (
Stifel Maintains Buy on Galmed Pharmaceuticals, Lowers Price Target to $25
12:00am, Friday, 13'th Mar 2020The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2019 Financial Results
11:00am, Thursday, 12'th Mar 2020
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, curre
Earnings Scheduled For March 12, 2020
08:51am, Thursday, 12'th Mar 2020
Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estima
Galmed Pharmaceuticals Q4 EPS $(0.39) Misses $(0.34) Estimate
12:00am, Thursday, 12'th Mar 2020The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
